Rigel Pharmaceuticals, Inc.
(NASDAQ : RIGL)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
1.13%178.061.3%$463.32m
CELGCelgene Corporation
0.87%97.351.3%$421.76m
GILDGilead Sciences, Inc.
1.32%67.240.9%$393.65m
BIIBBiogen Inc.
2.17%232.611.3%$355.07m
ILMNIllumina, Inc.
2.11%351.273.5%$273.61m
REGNRegeneron Pharmaceuticals, Inc.
1.94%311.152.6%$233.42m
AAgilent Technologies, Inc.
0.62%70.401.6%$213.38m
VRTXVertex Pharmaceuticals Incorporated
2.18%173.931.9%$198.42m
ARRYArray BioPharma Inc.
57.08%46.488.2%$186.21m
EXASExact Sciences Corporation
0.94%110.8125.3%$184.59m
ALXNAlexion Pharmaceuticals, Inc.
2.25%120.582.0%$176.03m
BMRNBioMarin Pharmaceutical Inc.
4.18%84.224.3%$136.28m
MRTXMirati Therapeutics Inc.
6.98%100.842.5%$114.49m
IONSIonis Pharmaceuticals, Inc.
4.35%64.798.2%$97.14m
INCYIncyte Corporation
5.44%81.942.5%$92.05m

Company Profile

Rigel Pharmaceuticals, Inc. operates as a clinical stage biotechnology company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The firm focuses on intracellular signalling pathways and related targets that are critical to disease mechanisms. Its products include Tavalisse, Fostamatinib and R835. The company was founded by Donald G. Payan, James M. Gower, Thomas A. Raffin, Garry P. Nolan and Ronald B. Garren on June 14, 1996 and is headquartered in South San Francisco, CA.